Trial Profile
A prospective study of fingolimod in patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics; Therapeutic Use
- 26 Feb 2016 New trial record